A NOVEL FROZEN STORAGE SYSTEM FOR CORD BLOOD STEM CELLS

Information

  • Research Project
  • 6587002
  • ApplicationId
    6587002
  • Core Project Number
    R44HL065864
  • Full Project Number
    2R44HL065864-02A1
  • Serial Number
    65864
  • FOA Number
  • Sub Project Id
  • Project Start Date
    2/1/2003 - 21 years ago
  • Project End Date
    1/31/2005 - 19 years ago
  • Program Officer Name
    CHEUNG, GEOFFREY P.
  • Budget Start Date
    2/1/2003 - 21 years ago
  • Budget End Date
    1/31/2004 - 20 years ago
  • Fiscal Year
    2003
  • Support Year
    2
  • Suffix
    A1
  • Award Notice Date
    -

A NOVEL FROZEN STORAGE SYSTEM FOR CORD BLOOD STEM CELLS

DESCRIPTION (provided by applicant): With increasing effort directed toward purification and/or in vitro expansion of hematopoietic progenitor cells (HPCs) for either fundamental research or clinical applications, there is an associated, increased need for the development of improved, efficient preservation methods for these cells to provide "cell banks." In addition, with the increase in allograft of purified progenitor cells, the possibility of disease transmission from use of contaminated donor material requires that only cells from infectious disease-screened donors be used. The ability to store frozen cells would allow sufficient time for adequate screening to be performed. Therefore, the overall goal of this continuing research is to further develop and optimize an improved system for cryopreservation and storage of human placental/umbilical cord blood (PCB) derived hematopoietic progenitor cells (HPCs), especially as it relates to improving the retention of normal structure and function of frozen-thawed cells to improve clinical outcome (engraftment). In Phase I, a system was developed which provides (1) an efficient, simplified method of bulk-freezing HPC units, and (2) optimized removal of cryoprotectant (DMSO) while maintaining a closed system. In Phase II, this system will be refined to allow (1) ease of use in the clinical environment, and (2) ease of manufacture/commercialization. It is the goal of this Phase II proposal to refine the closed cryopreservation, storage, and PCB washing system based on sound biophysical cell-type specific characteristics and mathematical modeling which will allow efficient and safe use of cryopreserved PCB derived HPCs. To achieve this goal, the following specific aims are proposed: (1) Validation and refinement of the cryopreservation method/system-using colony forming assays in semi-solid media to determine clonogenic ability, (2) Validation and refinement using a human long-term culture initiating cell (LTC-IC) assay, and (3) Testing of the cryopreservation system by freezing/thawing/washing HPCs and transplanting into a NOD/SCID mouse model.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R44
  • Administering IC
    HL
  • Application Type
    2
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    501561
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    839
  • Ed Inst. Type
  • Funding ICs
    NHLBI:501561\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    GENERAL BIOTECHNOLOGY, LLC
  • Organization Department
  • Organization DUNS
    364285726
  • Organization City
    INDIANAPOLIS
  • Organization State
    IN
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    46202
  • Organization District
    UNITED STATES